Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Asset Utilization Ratio (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Asset Utilization Ratio data on record, last reported at 0.29 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 1310.51% year-over-year to 0.29; the TTM value through Sep 2025 reached 0.29, up 1310.51%, while the annual FY2024 figure was 0.17, N/A changed from the prior year.
  • Asset Utilization Ratio reached 0.29 in Q3 2025 per CYCN's latest filing, up from 0.23 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.29 in Q3 2025 and bottomed at 0.07 in Q2 2023.
  • Average Asset Utilization Ratio over 5 years is 0.08, with a median of 0.05 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: crashed 243.94% in 2023, then surged 1310.51% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then tumbled by 77.8% to 0.01 in 2022, then crashed by 585.14% to 0.07 in 2023, then surged by 424.09% to 0.22 in 2024, then soared by 33.28% to 0.29 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.29 in Q3 2025, 0.23 in Q2 2025, and 0.21 in Q1 2025.